GLP–GIP–Glucagon is a multi-receptor research peptide formulation designed to explore advanced metabolic regulation, energy balance, and hormonal signaling pathways. This compound targets three key pathways: GLP (glucagon-like peptide), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, making it a subject of significant interest in metabolic research. In experimental settings, GLP–GIP–Glucagon is studied for its potential to influence glucose metabolism, appetite regulation, and energy expenditure. By engaging multiple hormonal pathways, it may support coordinated metabolic responses, including nutrient utilization and overall energy homeostasis. This triple-agonist approach is also being explored for its potential role in weight-related research, insulin signaling, and metabolic efficiency. Its unique mechanism makes it a valuable compound in studies focused on complex metabolic interactions and endocrine system dynamics.